OBJECTIVE: To evaluate the effectiveness of the Nicotrol nicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. METHODS:Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. RESULTS: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was.77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. CONCLUSIONS:OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.
RCT Entities:
OBJECTIVE: To evaluate the effectiveness of the Nicotrolnicotine inhaler as an aid to smoking cessation in over-the-counter (OTC) versus health-care-provider (HCP) conditions. METHODS: Five hundred twenty healthy smokers were randomized to the treatment conditions and followed for a year. RESULTS: At most follow-up visits, abstinence rates for the HCP group were 2 to 3 times those observed in the OTC group. Abstinence at 1 year was.77% in the OTC condition versus 3.08% in the HCP condition [P<.01]. Inhaler use was low. CONCLUSIONS: OTC nicotine inhaler appears to be ineffective, though quit rates are improved with HCP assistance.
Authors: Taneisha S Buchanan; Carla J Berg; Lisa Sanderson Cox; Niaman Nazir; Neal L Benowitz; Lisa Yu; Olivia Yturralde; Peyton Jacob; Won S Choi; Jasjit S Ahluwalia; Nicole L Nollen Journal: Nicotine Tob Res Date: 2012-02-24 Impact factor: 4.244
Authors: Nicole L Nollen; Lisa Sanderson Cox; Niaman Nazir; Edward F Ellerbeck; Ashli Owen; Sydni Pankey; Nia Thompson; Jasjit S Ahluwalia Journal: Nicotine Tob Res Date: 2011-04-15 Impact factor: 4.244
Authors: Judith S Gordon; Julie S Armin; James K Cunningham; Myra L Muramoto; Steven M Christiansen; Thomas A Jacobs Journal: Patient Educ Couns Date: 2016-11-08
Authors: Karen Ahijevych; Beverly J Tepper; Margaret C Graham; Christopher Holloman; William A Matcham Journal: Nicotine Tob Res Date: 2014-12-26 Impact factor: 4.244
Authors: Christopher Deutsch; Beth C Bock; Ryan Lantini; Kristen Walaska; Rochelle K Rosen; Joseph L Fava; Ernestine G Jennings; Robert Foster; William Flanagan Journal: Contemp Clin Trials Date: 2019-04-15 Impact factor: 2.226